Seminal Canadian Recommendations for Evidence Based Examination of Neonates for Retinopathy of Prematurity (SCREEN-ROP)
SCREEN-ROP is the first national study of its kind and aims to set the first, evidence-based Canadian guidelines for screening newborns for ROP.
Retinopathy of Prematurity (ROP) is a potentially blinding eye disease which affects prematurely born children in the neonatal period. Every year, thousands of newborns are examined across Canada in order to capture the few hundred who develop severe ROP. Those with severe disease require urgent treatment in order to prevent blindness. Currently there are no universally accepted national guidelines regarding which neonates should be screened for ROP. SCREEN-ROP is the first national study of its kind and aims to set the first, evidence-based Canadian guidelines for screening newborns for ROP.
Slated for Publication: Sabri K, Shivananda, S., Selvitella A, Easterbrook, B, Seidlitz, W, Lee, SK. Refining evidence-based retinopathy of prematurity screening guidelines: The SCREENROP Study. Paediatrics & Child Health. 2019
Clinical Studies, ResearchRelated News
News Listing
Two Faculty of Health Sciences cancer researchers awarded Canada Research Chairs
Dept. Biochem, Dept. Surgery, Feature, Research
June 27, 2024
Elena Verdu appointed director of Farncombe Family Digestive Health Research Institute
Faculty & Staff, Research
June 27, 2024